2023 June Inhalation HW Boston


Gemma Budd is Business Development Director for Nanopharm, an Aptar Pharma company, where she is primarily responsible for developing business and collaborative opportunities for Aptar Pharma’s services, solutions and technologies in the orally inhaled and nasal drug product sector. With a university degree in Biomedical Sciences, Ms Budd has more than 10 years of experience in the pharmaceutical industry in both research and commercial positions, from materials science and analytical services to formulation technology and drug delivery devices, primarily for oral and inhaled dosage forms.